Skip to main content

. 1986;22(Suppl 1):83S–100S. doi: 10.1111/j.1365-2125.1986.tb02988.x

Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries

PMCID: PMC1401013 PMID: 3567037

86S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brearley R. Green College lectures: 1984. Medicine in the European communities. Br Med J (Clin Res Ed) 1984 May 5;288(6427):1360–1363. doi: 10.1136/bmj.288.6427.1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
Burkholder D. F. Adverse drug effects and their impact on patient care: a review of the problem. Drug Intell Clin Pharm. 1979 Jul-Aug;13(7-8):421–424. doi: 10.1177/106002807901300708. [DOI] [PubMed] [Google Scholar]
Idänpän-Heikkilä J., Alhava E., Olkinuora M., Palva I. Letter: Clozapine and agranulocytosis. Lancet. 1975 Sep 27;2(7935):611–611. doi: 10.1016/s0140-6736(75)90206-8. [DOI] [PubMed] [Google Scholar]
Penn R. G., Griffin J. P. Adverse reactions to nitrofurantoin in the United Kingdom, Sweden, and Holland. Br Med J (Clin Res Ed) 1982 May 15;284(6327):1440–1442. doi: 10.1136/bmj.284.6327.1440. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES